Vanessa Trump opens up about her cancer journey.
Australian scientists have led a world-first breakthrough in a personalised mRNA melanoma vaccine that is showing remarkable ...
Vancouver's James Howard is paying $90,000 a month for a new pancreatic cancer treatment that may add a few more months to his life. But, he's far from the only Canadian who is faced with having to ...
News On 6 on MSN
Male breast cancer: What symptoms should men look for, and why does early detection matter?
October is Breast Cancer Awareness Month, a time when many conversations focus on women's risk and the importance of ...
A radioactive treatment for advanced prostate cancer produced encouraging results in routine French medical practice, ...
GSK Plc (LON:GSK) said on Monday its immunotherapy Jemperli cleared tumours completely in 76% of patients with a certain type ...
Expert and company perspectives on the role of amivantamab in advancing first-line treatment “Patients with recurrent or metastatic head and neck cancer continue to face a poor prognosis, highlighting ...
OncoHost, a technology company transforming the approach to predictive precision diagnostics for improved patient outcomes, today announced new research that was presented at the European Society for ...
An analysis of United States data reveals a broad shift away from overtreatment of low-risk prostate cancer. The analysis ...
Scientists have found a previously overlooked way lung tumors may weaken an immune-defense signal, potentially helping explain why some patients do not benefit from immunotherapy. The discovery ...
On October 23, 2026, the New England Journal of Medicine (NEJM) published a new Phase III trial regarding first-line ...
The cohort met its primary endpoint of major pathologic response, with 83% of patients having little or no cancer remaining ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results